Pfizer Inc (PFE)
26.44
+0.18
(+0.69%)
USD |
NYSE |
Apr 23, 10:07
Pfizer Total Liabilities (Quarterly): 137.21B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 137.21B |
| September 30, 2023 | 117.82B |
| June 30, 2023 | 120.88B |
| March 31, 2023 | 94.38B |
| December 31, 2022 | 101.29B |
| September 30, 2022 | 102.46B |
| June 30, 2022 | 107.82B |
| March 31, 2022 | 101.16B |
| December 31, 2021 | 104.01B |
| September 30, 2021 | 103.22B |
| June 30, 2021 | 99.60B |
| March 31, 2021 | 89.95B |
| December 31, 2020 | 90.76B |
| September 30, 2020 | 113.49B |
| June 30, 2020 | 113.37B |
| March 31, 2020 | 101.00B |
| December 31, 2019 | 104.15B |
| September 30, 2019 | 105.05B |
| June 30, 2019 | 96.28B |
| March 31, 2019 | 96.26B |
| December 31, 2018 | 95.66B |
| September 30, 2018 | 96.17B |
| June 30, 2018 | 94.86B |
| March 31, 2018 | 94.07B |
| December 31, 2017 | 100.14B |
| Date | Value |
|---|---|
| September 30, 2017 | 111.04B |
| June 30, 2017 | 109.86B |
| March 31, 2017 | 110.04B |
| December 31, 2016 | 111.78B |
| September 30, 2016 | 114.83B |
| June 30, 2016 | 107.59B |
| March 31, 2016 | 99.58B |
| December 31, 2015 | 102.38B |
| September 30, 2015 | 103.74B |
| June 30, 2015 | 93.70B |
| March 31, 2015 | 93.05B |
| December 31, 2014 | 95.94B |
| September 30, 2014 | 93.06B |
| June 30, 2014 | 95.66B |
| March 31, 2014 | 93.74B |
| December 31, 2013 | 95.48B |
| September 30, 2013 | 97.17B |
| June 30, 2013 | 100.36B |
| March 31, 2013 | 104.57B |
| December 31, 2012 | 104.12B |
| September 30, 2012 | 100.49B |
| June 30, 2012 | 102.88B |
| March 31, 2012 | 102.01B |
| December 31, 2011 | 105.38B |
| September 30, 2011 | 105.60B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
89.95B
Minimum
Mar 2021
137.21B
Maximum
Dec 2023
105.47B
Average
103.22B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 90.92B |
| Gilead Sciences Inc | 39.38B |
| Johnson & Johnson | 98.78B |
| Viking Therapeutics Inc | 20.07M |
| Moderna Inc | 4.572B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 226.50B |
| Shareholders Equity (Quarterly) | 89.01B |
| Debt to Equity Ratio | 0.7959 |
| Current Ratio | 0.9067 |
| Net Debt Paydown Yield | -4.33% |